Applications including "United States Pharmacopoeia"

LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC InertSearch Inertsil ODS-HL
LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC InertSearch InertSustainSwift C18
LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC InertSearch Inertsil NH2
LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch Inertsil ODS-3
LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch InertSustain C18
LB991 - Analysis of Progestrone and Methyltestrone -

LC InertSearch Inertsil WP300 C18
LB985 - Analysis of Sumatriptan -

LC InertSearch Inertsil ODS-3
LB984 - Analysis of Sumatriptan -

LC InertSearch InertSustain AQ-C18
LB982 - Analysis of Ofloxacin -

LC InertSearch InertSustain C18
LB981 - Analysis of Ofloxacin -

LC InertSearch Inertsil WP300 C18
LB980 - Analysis of Desloratadine -

LC InertSearch InertSustain AQ-C18
LB961 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB960 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LT147 - D-Mannitol Analysis Under USP Method -

LC Technical Note InertSphere Sugar-2 HAMILTON HC-75（Ca2+）
LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP） -

LC Technical Note
GT093 - Quantitative Test for Hydroxypropylcellulose with Reference to the Japanese Pharmacopoeia, 17th Edition -

GC Technical Note InertCap 1 InertCap Series
GT086 - Purity Test and Fatty Acid Content Ratio Test of Polysorbate 80 - Supplement II to the Japanese Pharmacopoeia, 16th Edition -

GC Technical Note InertCap Pure-WAX InertCap 5

Applications including "United States Pharmacopoeia"

LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LB991 - Analysis of Progestrone and Methyltestrone -

LB985 - Analysis of Sumatriptan -

LB984 - Analysis of Sumatriptan -

LB982 - Analysis of Ofloxacin -

LB981 - Analysis of Ofloxacin -

LB980 - Analysis of Desloratadine -

LB961 - Analysis of Lidocaine -

LB960 - Analysis of Lidocaine -

LT147 - D-Mannitol Analysis Under USP Method -

LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP） -

GT093 - Quantitative Test for Hydroxypropylcellulose with Reference to the Japanese Pharmacopoeia, 17th Edition -

GT086 - Purity Test and Fatty Acid Content Ratio Test of Polysorbate 80 - Supplement II to the Japanese Pharmacopoeia, 16th Edition -

Application Search